BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19298896)

  • 1. [Morphologic and molecular neuropathology of Alzheimer's disease].
    Duyckaerts C; Panchal M; Delatour B; Potier MC
    Ann Pharm Fr; 2009 Mar; 67(2):127-35. PubMed ID: 19298896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
    Dessi F; Colle MA; Hauw JJ; Duyckaerts C
    Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the neuropathology of familial Alzheimer's disease.
    Shepherd C; McCann H; Halliday GM
    Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and basic pathology of Alzheimer disease.
    Duyckaerts C; Delatour B; Potier MC
    Acta Neuropathol; 2009 Jul; 118(1):5-36. PubMed ID: 19381658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer disease.
    Calderon-Garcidueñas AL; Duyckaerts C
    Handb Clin Neurol; 2017; 145():325-337. PubMed ID: 28987180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
    Yeh HL; Tsai SJ
    Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of dementias and implications for therapy.
    Roy OW; Cohen NR; Nicoll JA
    Indian J Pathol Microbiol; 2005 Jul; 48(3):289-99. PubMed ID: 16761736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
    Jellinger KA
    Neurodegener Dis; 2008; 5(3-4):118-21. PubMed ID: 18322367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer's disease lesions: from morphology to cell biology].
    Hauw JJ; Seilhean D; Piette F; Uchihara T; Duyckaerts C
    Bull Acad Natl Med; 1996 Oct; 180(7):1687-700; discussion 1700-1. PubMed ID: 9102151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
    Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
    Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimer's disease patients.
    Ojida A; Sakamoto T; Inoue MA; Fujishima SH; Lippens G; Hamachi I
    J Am Chem Soc; 2009 May; 131(18):6543-8. PubMed ID: 19368380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
    Castellani RJ; Lee HG; Zhu X; Nunomura A; Perry G; Smith MA
    Acta Neuropathol; 2006 Jun; 111(6):503-9. PubMed ID: 16718346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response.
    Götz J; David D; Hoerndli F; Ke YD; Schonrock N; Wiesner A; Fath T; Bokhari L; Lim YA; Deters N; Ittner LM
    Neurodegener Dis; 2008; 5(3-4):179-81. PubMed ID: 18322384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology of Alzheimer disease].
    Braak H; Braak E
    Fortschr Med; 1990 Nov; 108(33):621-4. PubMed ID: 2289729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of silver techniques for studying the pathology of Alzheimer's disease.
    Tsamis K; Mytilinaios D; Njau SN; Psaroulis D; Mavroudis J; Costa V; Baloyannis SJ
    Int J Neurosci; 2008 Feb; 118(2):257-66. PubMed ID: 18205081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.